Recent Development of Rhenium-Based Materials in the Application of Diagnosis and Tumor Therapy

Author:

Qi Qingwen1,Wang Qian1,Li Yuhao12ORCID,Silva Dionisio Zaldivar23ORCID,Ruiz Maria Eliana Lanio23,Ouyang Ruizhuo12ORCID,Liu Baolin24,Miao Yuqing12

Affiliation:

1. School of Materials and Chemistry, Institute of Bismuth and Rhenium, University of Shanghai for Science and Technology, Shanghai 200093, China

2. USST-UH International Joint Laboratory for Tumor Diagnosis and Energy Treatment, University of Shanghai for Science and Technology, Shanghai 200093, China

3. Faculty of Biology, University of Havana, Havana 10400, Cuba

4. School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China

Abstract

Rhenium (Re) is widely used in the diagnosis and treatment of cancer due to its unique physical and chemical properties. Re has more valence electrons in its outer shell, allowing it to exist in a variety of oxidation states and to form different geometric configurations with many different ligands. The luminescence properties, lipophilicity, and cytotoxicity of complexes can be adjusted by changing the ligand of Re. This article mainly reviews the development of radionuclide 188Re in radiotherapy and some innovative applications of Re as well as the different therapeutic approaches and imaging techniques used in cancer therapy. In addition, the current application and future challenges and opportunities of Re are also discussed.

Funder

the Natural Science Foundation of Shanghai

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Reference142 articles.

1. The potential relationships between aging and cancer;Williams;Exp. Gerontol.,1992

2. Relationships between cancer and aging: A multilevel approach;Anisimov;Biogerontology,2009

3. What has senescence got to do with cancer?;Dimri;Cancer Cell,2005

4. Exposure to carcinogens and its effects in the formation of cancer;Xiaowei;J. Cancer Res. Immunooncol.,2020

5. The relationship between aging and carcinogenesis: A critical appraisal;Anisimov;Crit. Rev. Oncol. Hematol.,2003

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Topochemical-like bandgap regulation engineering: A bismuth thiooxide nanocatalyst for breast cancer phototherapy;Journal of Colloid and Interface Science;2024-05

2. Brain Tumor Localization and Multimodal Segmentation in MRI Images by Automated Process;2024 International Conference on Knowledge Engineering and Communication Systems (ICKECS);2024-04-18

3. Acid-Responsive Bismuth Heterojunction Nanocatalyst for Photocatalytic and Photothermal Treatment of Tumors;ACS Applied Nano Materials;2024-03-28

4. Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2024-02-28

5. Two rhenium compounds with benzimidazole ligands: synthesis and DNA interactions;RSC Advances;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3